Detalhe da pesquisa
1.
Dynamic Profiling of the Immune Tumor Microenvironment in Locally Advanced Gastric Cancer Treated with Perioperative Chemotherapy.
Oncology
; 101(7): 435-445, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307799
2.
HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer.
Oncologist
; 25(10): 886-893, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32353192
3.
Immune Checkpoint Inhibitors in Esophageal Cancers: are we Finally Finding the Right Path in the Mist?
Int J Mol Sci
; 21(5)2020 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32121290
4.
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.
Br J Cancer
; 120(5): 522-526, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745584
5.
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.
Future Oncol
; 13(25): 2265-2275, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28976226
6.
First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors.
Int J Cancer
; 139(4): 938-45, 2016 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27038273
7.
Third-Line Chemotherapy with Irinotecan plus 5-Fluorouracil in Caucasian Metastatic Gastric Cancer Patients.
Oncology
; 91(6): 311-316, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27705972
8.
Second-line therapy for advanced pancreatic cancer: evaluation of prognostic factors and review of current literature.
Future Oncol
; 12(7): 901-8, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26883177
9.
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.
Lancet Oncol
; 14(1): 55-63, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23182627
10.
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer.
Am J Cancer Res
; 12(7): 3347-3356, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35968330
11.
Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients.
J Clin Med
; 10(5)2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33807648
12.
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
Eur J Cancer
; 137: 108-116, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32750500
13.
5-fluorouracil pharmacokinetics predicts disease-free survival in patients administered adjuvant chemotherapy for colorectal cancer.
Clin Cancer Res
; 14(9): 2749-55, 2008 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18451241
14.
Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study.
Cancers (Basel)
; 11(7)2019 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31277449
15.
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Cancer Biomark
; 21(3): 731-741, 2018 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278885
16.
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma.
Oncotarget
; 8(9): 14408-14415, 2017 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122337
17.
Prognostic Significance of 2-Deoxy-2-[18F]-Fluoro-D-Glucose PET/CT in Patients With Locally Advanced Esophageal Cancer Undergoing Neoadjuvant Chemoradiotherapy Before Surgery: A Nonparametric Approach.
Medicine (Baltimore)
; 95(13): e3151, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27043676
18.
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.
Oncotarget
; 7(45): 72622-72633, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27579536
19.
Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma.
Cancer Chemother Pharmacol
; 69(3): 773-80, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22033636
20.
A single-institutional brachytherapy experience in the management of esophageal cancer.
Brachytherapy
; 9(2): 185-91, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-19875341